0597-0270Level 3
Jentadueto XR (linagliptin and metformin hydrochloride)
**Product type:** Human Prescription Drug
**Active ingredient:** LINAGLIPTIN; METFORMIN HYDROCHLORIDE
**Strength:** 2.5; 1000 mg/1; mg/1
**Dosage form:** Tablet, Film Coated, Extended Release
**Route:** Oral
**Labeler:** Boehringer Ingelheim Pharmaceuticals, Inc.
**Marketing category:** NDA (NDA208026)
**Pharmacologic class:** Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/0597-0270Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.